Apimeds Pharmaceuticals US, Inc. Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin 2,042.85%1,180.77%
EBIT Margin 1,963.37%1,083.17%
EBITDA Margin 1,963.37%1,083.17%
Operating Margin 1,963.37%1,083.17%
Net Margin 2,042.85%1,180.77%
FCF Margin 1,649.08%623.12%
Leverage & Solvency
Interest Coverage Ratio -19.63-10.83
Times Interest Earned -19.63-10.83
Return Ratios
Return on Sales 20.43%11.81%